They showed that CDKL3 exerts tumor-promotor-like functions in the development of ESCC, with upregulated expression in tumor tissues, a significant correlation with poor prognosis of patients, a distinct regulatory ability of malignant cell phenotypes [17]. Here, CDKL3 is linked to neoplasm.